The COVID-19 pandemic has upended the clinical trial landscape in ways large and small, agreed experts on the final day of the ACRP 2021 virtual conference's January track (January 14). […]
Calling it a “timely conversation,” Eric Pittman, director of the Bioresearch Monitoring Division at the U.S. Food and Drug Administration (FDA), told attendees of the second day of the ACRP […]
Fresh from a huge and successful project putting together a COVID-19 biorepository, leaders at the Medical University of South Carolina (MUSC) shared some best practices with attendees of the first […]
While there is currently no cure for fatty liver disease (FLD) or nonalcoholic steatohepatitis (NASH), a condition to which FLD can lead, the pharmaceutical industry is turning to clinical research […]
The U.S. Food and Drug Administration (FDA) is taking a look in the mirror as the new year gets under way, and is liking most of what it sees. Working […]